1. Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data. Issue 11 (5th August 2020) Authors: Mease, Philip; Charles-Schoeman, Christina; Cohen, Stanley; Fallon, Lara; Woolcott, John; Yun, Huifeng; Kremer, Joel; Greenberg, Jeffrey; Malley, Wendi; Onofrei, Alina; Kanik, Keith S; Graham, Daniela; Wang, Cunshan; Connell, Carol; Valdez, Hernan; Hauben, Manfred; Hung, Eric; Madsen, Ann; Jones,... Journal: Annals of the rheumatic diseases Issue: Volume 79:Issue 11(2020) Page Start: 1400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study. (April 2021) Authors: Nash, Peter; Coates, Laura C; Fleishaker, Dona; Kivitz, Alan J; Mease, Philip J; Gladman, Dafna D; FitzGerald, Oliver; Wang, Cunshan; Wu, Joseph; Hsu, Ming-Ann; Menon, Sujatha; Fallon, Lara; Kanik, Keith S Journal: Lancet Issue: Volume 3:Number 4(2021) Page Start: e270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis. (3rd April 2018) Authors: Veale, Douglas J; McGonagle, Dennis; McInnes, Iain B; Krueger, James G; Ritchlin, Christopher T; Elewaut, Dirk; Kanik, Keith S; Hendrikx, Thijs; Berstein, Gabriel; Hodge, Jennifer; Telliez, Jean-Baptiste Journal: Rheumatology Issue: Volume 58:Number 2(2019) Page Start: 197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance. (January 2021) Authors: Nash, Peter; Mease, Philip J; Fleishaker, Dona; Wu, Joseph; Coates, Laura C; Behrens, Frank; Gladman, Dafna D; Kivitz, Alan J; Wei, James C; Shirinsky, Ivan; Menon, Sujatha; Romero, Ana B; Fallon, Lara; Hsu, Ming-Ann; Wang, Cunshan; Kanik, Keith S Journal: Lancet Issue: Volume 3:Number 1(2021) Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study. Issue 8 (27th April 2021) Authors: Deodhar, Atul; Sliwinska-Stanczyk, Paula; Xu, Huji; Baraliakos, Xenofon; Gensler, Lianne S; Fleishaker, Dona; Wang, Lisy; Wu, Joseph; Menon, Sujatha; Wang, Cunshan; Dina, Oluwaseyi; Fallon, Lara; Kanik, Keith S; van der Heijde, Désirée Journal: Annals of the rheumatic diseases Issue: Volume 80:Issue 8(2021) Page Start: 1004 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial. Issue 10315 (27th November 2021) Authors: Ruperto, Nicolino; Brunner, Hermine I; Synoverska, Olga; Ting, Tracy V; Mendoza, Carlos Abud; Spindler, Alberto; Vyzhga, Yulia; Marzan, Katherine; Grebenkina, Lyudmila; Tirosh, Irit; Imundo, Lisa; Jerath, Rita; Kingsbury, Daniel J; Sozeri, Betul; Vora, Sheetal S; Prahalad, Sampath; Zholobova, Ele... Journal: Lancet Issue: Volume 398:Issue 10315(2021) Page Start: 1984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study. Issue 8 (27th January 2017) Authors: van der Heijde, Désirée; Deodhar, Atul; Wei, James C; Drescher, Edit; Fleishaker, Dona; Hendrikx, Thijs; Li, David; Menon, Sujatha; Kanik, Keith S Journal: Annals of the rheumatic diseases Issue: Volume 76:Issue 8(2017) Page Start: 1340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients. (26th April 2018) Authors: Maksymowych, Walter P; Heijde, Désirée van der; Baraliakos, Xenofon; Deodhar, Atul; Sherlock, Sarah P; Li, David; Fleishaker, Dona; Hendrikx, Thijs; Kanik, Keith S Journal: Rheumatology Issue: Volume 57:Number 8(2018) Page Start: 1390 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗